Literature DB >> 12183248

Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.

Philipp M Lepper1, Eberhard Grusa, Helga Reichl, Josef Högel, Matthias Trautmann.   

Abstract

It is generally assumed that the antibiotic prescription policy of a hospital has a significant impact on bacterial resistance rates; however, few studies are available to support this concept with valid statistical data. During a 3-year period from 1997 to 2000, we monitored the consumption of beta-lactam and other antibiotics with known activity against Pseudomonas aeruginosa in a 600-bed community hospital. Monthly isolations of P. aeruginosa were assessed, and resistance rates were recorded. Partial correlation coefficients between consumption and resistance rates were determined, taking into account possible associations with other variables such as seasonal effects and transfers from other hospitals. A total of 30 +/- 7 novel P. aeruginosa strains per month were isolated without epidemic clustering. Prescriptions of imipenem varied significantly during the study period, while prescriptions of other antipseudomonal agents were stable, with the exception of an increase in piperacillin-tazobactam prescriptions. Rates of resistance of P. aeruginosa to the antimicrobial agents used showed a time course similar to figures for imipenem consumption. Monthly rates of resistance to imipenem (partial correlation coefficient [cc], 0.63), piperacillin-tazobactam (cc, 0.57), and ceftazidime (cc, 0.56) were significantly associated with imipenem prescription rates in the same or the preceding month, while consumption of ceftazidime or piperacillin-tazobactam had no apparent association with resistance. Among the variables investigated, imipenem consumption was identified as the major factor associated with both carbapenem and beta-lactam resistance in endemic P. aeruginosa. Periods of extensive imipenem use were associated with significant increases in resistance. Our data support the concept that a written antibiotic policy which balances the use of various antibiotic classes may help to avoid disturbances of a hospital's microbial sensitivity patterns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183248      PMCID: PMC127431          DOI: 10.1128/AAC.46.9.2920-2925.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.

Authors:  J M López-Lozano; D L Monnet; A Yagüe; A Burgos; N Gonzalo; P Campillos; M Saez
Journal:  Int J Antimicrob Agents       Date:  2000-02       Impact factor: 5.283

2.  Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.

Authors:  D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period.

Authors:  O Lyytikäinen; M Vaara; E Järviluoma; K Rosenqvist; L Tiittanen; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

4.  Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

Authors:  D Gruson; G Hilbert; F Vargas; R Valentino; C Bebear; A Allery; C Bebear; G Gbikpi-Benissan; J P Cardinaud
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

5.  [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].

Authors:  A C Rodloff; H J Laubenthal; A Bastian; K Bestehorn; G Büchele; W Gaus
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  1996-04       Impact factor: 0.698

6.  Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.

Authors:  Anthony D Harris; David Smith; Judith A Johnson; Douglas D Bradham; Mary-Claire Roghmann
Journal:  Clin Infect Dis       Date:  2001-12-26       Impact factor: 9.079

7.  Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors:  W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Emergence of vancomycin-resistant enterococci in New York City.

Authors:  T R Frieden; S S Munsiff; D E Low; B M Willey; G Williams; Y Faur; W Eisner; S Warren; B Kreiswirth
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

9.  Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.

Authors:  A Cometta; J D Baumgartner; D Lew; W Zimmerli; D Pittet; P Chopart; U Schaad; C Herter; P Eggimann; O Huber
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.

Authors:  F Tausk; M E Evans; L S Patterson; C F Federspiel; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  26 in total

1.  Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.

Authors:  Yi-Chia Lee; Jyh-Ming Liou; Ming-Shiang Wu; Chun-Ying Wu; Jaw-Town Lin
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

2.  Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014.

Authors:  Marta Mascarello; Omar Simonetti; Anna Knezevich; Ludovica Ilaria Carniel; Jacopo Monticelli; Marina Busetti; Paolo Schincariol; Lucio Torelli; Roberto Luzzati
Journal:  Infection       Date:  2017-03-06       Impact factor: 3.553

3.  Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis.

Authors:  T Delory; A De Pontfarcy; A Emirian; F About; B Berdougo; C Brun-Buisson; P Lesprit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-10       Impact factor: 3.267

4.  Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.

Authors:  Takeshi Kimura; Atsushi Uda; Tomoyuki Sakaue; Kazuhiko Yamashita; Tatsuya Nishioka; Sho Nishimura; Kei Ebisawa; Manabu Nagata; Goh Ohji; Tatsuya Nakamura; Chihiro Koike; Mari Kusuki; Takeshi Ioroi; Akira Mukai; Yasuhisa Abe; Hiroyuki Yoshida; Midori Hirai; Soichi Arakawa; Ikuko Yano; Kentaro Iwata; Issei Tokimatsu
Journal:  Infection       Date:  2017-11-13       Impact factor: 3.553

5.  Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital.

Authors:  G Samonis; I P Korbila; S Maraki; I Michailidou; K Z Vardakas; D Kofteridis; D Dimopoulou; V K Gkogkozotou; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-15       Impact factor: 3.267

6.  Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.

Authors:  Noyal Mariya Joseph; B Bhanupriya; Deepak Gopal Shewade; Belgode Narasimha Harish
Journal:  J Clin Diagn Res       Date:  2015-02-01

7.  Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.

Authors:  Jae-Hoon Ko; Cheol-In Kang; Woo Joo Lee; Kyungmin Huh; Jeong Rae Yoo; Kwangmin Kim; Sun Young Cho; Young Eun Ha; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck; Jae-Hoon Song
Journal:  Support Care Cancer       Date:  2014-08-12       Impact factor: 3.603

8.  Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013).

Authors:  Y M Zou; Y Ma; J H Liu; J Shi; T Fan; Y Y Shan; H P Yao; Y L Dong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-10       Impact factor: 3.267

9.  Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?

Authors:  C Plüss-Suard; A Pannatier; A Kronenberg; K Mühlemann; G Zanetti
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

10.  Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit.

Authors:  Hatem Kallel; Fouzia Mahjoubi; Hassen Dammak; Mabrouk Bahloul; Chokri Ben Hamida; Hedi Chelly; Noureddine Rekik; Adnéne Hammami; Mounir Bouaziz
Journal:  Indian J Crit Care Med       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.